+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Smart Implantable Pumps Market - Global Forecast 2026-2032- Product Image
Smart Implantable Pumps Market - Global Forecast 2026-2032- Product Image
Sale

Smart Implantable Pumps Market - Global Forecast 2026-2032

  • Report

  • 192 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 6011839
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Smart Implantable Pumps Market is projected to reach USD 3.19 Billion in 2026. It is expected to continue growing at a CAGR of 7.87%, reaching USD 5.07 Billion by 2032.

Smart implantable pumps are moving from niche life-supporting devices to digitally enabled drug delivery platforms used in chronic pain, severe spasticity, oncology pain management, and select endocrine or neurologic applications. The core value proposition is clinically proven: programmable implanted infusion can deliver precise micro-doses directly to a target site, such as the intrathecal space, reducing systemic exposure compared with oral or parenteral regimens and supporting personalized therapy over long treatment durations.

Market relevance is supported by structural healthcare trends, including aging populations, rising chronic disease burden, demand for long-term ambulatory therapy, and pressure to reduce hospital-based care. Because implantable infusion pumps are typically treated as high-risk medical devices by regulators such as the U.S. FDA and must meet rigorous safety, biocompatibility, software, labeling, and post-market surveillance requirements, competitive advantage increasingly depends on evidence generation, device reliability, cybersecurity, refill workflow efficiency, and connected care capabilities.

Transformative Shifts in the Smart Pump Landscape

The smart implantable pumps landscape is being reshaped by four converging shifts: miniaturized electronics, low-power telemetry, advanced biomaterials, and value-based clinical pathways. Hospitals and specialty clinics are prioritizing programmable systems that can support dose titration, refill planning, event logging, and remote workflow integration while maintaining fail-safe mechanical performance in safety-critical drug delivery settings.

At the same time, healthcare systems are scrutinizing total cost of care and long-term therapy management. This favors pumps that reduce medication waste, improve adherence, limit breakthrough symptoms, and support predictable follow-up schedules. Manufacturers must also address established constraints, including surgical implantation requirements, infection risk, catheter complications, refill burden, battery life, MRI compatibility, alarm reliability, and clinician training needs.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is adding cumulative value across the implantable pump lifecycle rather than replacing clinician decision-making. In development, AI-enabled simulation can accelerate fluid dynamics modeling, battery optimization, failure mode analysis, and software verification. In manufacturing, machine learning supports process control, anomaly detection, and quality documentation aligned with regulated medical device production.

In clinical use, AI can help identify refill risk, flag abnormal dosing patterns, support predictive maintenance, and combine pump data with electronic health records to guide follow-up. The opportunity is strongest where AI remains explainable, validated, and compliant with FDA, EU MDR, data protection, and cybersecurity expectations because implantable drug delivery requires exceptionally high confidence in safety-critical performance and physician-supervised therapy decisions.

Key Regional Insights

North America remains a leading region due to advanced pain and spasticity care infrastructure, FDA-regulated innovation pathways, established reimbursement mechanisms, and strong adoption of programmable intrathecal drug delivery in specialist centers. Europe benefits from mature neuromodulation and infusion therapy networks, but EU Medical Device Regulation has raised clinical evidence, quality management, and post-market compliance expectations, lengthening some commercialization timelines while improving surveillance rigor.

Asia-Pacific is the fastest-evolving opportunity zone as Japan, China, South Korea, Australia, India, and ASEAN markets expand specialty care capacity, tertiary hospital networks, and local medtech production. Latin America, led by Brazil and Mexico, shows selective adoption in private and tertiary public hospitals where neurosurgery, oncology, rehabilitation, and pain medicine services are concentrated. The Middle East is investing in advanced specialty care across GCC health systems, supported by hospital modernization and referral-center development. Africa remains earlier stage, with adoption concentrated in major urban referral centers where neurosurgery, pain medicine, trained clinical teams, and refill logistics are available.

Key Group Insights

The G7 anchors premium demand through high healthcare spending, specialist physician access, established regulatory oversight, and stronger infrastructure for implanted drug delivery follow-up. The European Union creates a large harmonized regulatory environment shaped by MDR, clinical evidence requirements, vigilance obligations, and cross-border health technology assessment priorities. NATO countries overlap with several high-income medtech markets where supply chain resilience, cybersecurity, and trusted-device procurement are increasingly important for connected implantable systems.

BRICS markets represent long-term volume potential because of large patient populations, rising chronic disease needs, and expanding tertiary care, but pricing, reimbursement, local registration, and service-network complexity require country-specific strategies. ASEAN is gaining relevance through medical tourism, public hospital modernization, and local distribution partnerships that improve access to advanced pain and neurology care. The GCC is a high-value cluster where government-backed hospital investment, specialty centers, and international clinical collaborations support adoption of advanced implantable technologies.

Key Country Insights

The United States is the most influential country market, supported by FDA oversight, large pain and neuromodulation ecosystems, specialist implantation expertise, and reimbursement pathways for implanted drug delivery. Canada follows evidence-based adoption through provincial systems, while Mexico and Brazil offer regional growth through private hospitals and major urban specialty centers. In Europe, the United Kingdom, Germany, France, Italy, and Spain combine strong clinical expertise with cost-effectiveness scrutiny and structured procurement; Russia presents more variable access due to procurement complexity, import dependency, and geopolitical constraints.

China and India offer substantial long-term demand as neurology, oncology, rehabilitation, and pain services expand, though affordability, reimbursement coverage, local registration, and service access remain decisive. Japan and South Korea provide high-quality regulatory and clinical environments for advanced programmable devices, with strong hospital infrastructure and clinician specialization. Australia supports adoption through specialist centers and structured reimbursement pathways. Across all countries, success depends on clinician training, refill network density, regulatory documentation, reliable technical support, and local service capability.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize evidence-backed differentiation, focusing on reduced adverse events, reliable drug delivery accuracy, longer service life, stronger alarm functionality, and measurable improvements in patient quality of life. Investment in real-world evidence registries, post-market surveillance, human factors engineering, and usability validation will be essential as regulators and payers demand proof beyond technical performance.

Commercial strategy should combine specialist education, refill pathway optimization, cybersecurity-by-design, and partnerships with pain, neurology, oncology, and rehabilitation centers. Companies should also localize market access plans, build resilient component supply chains, ensure MRI and software documentation readiness, and prepare AI-enabled features with transparent validation, clinical governance, auditability, and clear physician control.

Research Methodology

This executive summary is developed using a structured secondary research approach consistent with industry research best practices. Inputs include publicly available regulatory guidance, medical device classification principles, peer-reviewed clinical literature on intrathecal drug delivery and programmable infusion, hospital adoption patterns, reimbursement considerations, cybersecurity expectations, and macro healthcare indicators.

The analysis triangulates clinical utility, regulatory requirements, technology readiness, regional healthcare infrastructure, market access dynamics, and service delivery constraints. No unsupported market-size figures are used; conclusions are framed around verifiable industry drivers, recognized regulatory realities, clinical workflow requirements, and observable adoption enablers across major geographies.

Conclusion

Smart implantable pumps are positioned for sustained strategic relevance as healthcare systems seek precision drug delivery, long-term symptom control, and lower systemic medication burden. The market is not defined only by device hardware; it is increasingly shaped by software reliability, data integrity, clinical service models, cybersecurity, refill operations, and post-implant support.

The next competitive cycle will favor organizations that combine implant reliability with connected workflows, validated AI support, strong cybersecurity, and region-specific access strategies. In this environment, evidence quality, clinician trust, patient safety, and lifecycle service excellence will determine durable leadership in smart implantable drug delivery.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Smart Implantable Pumps Market, by Product Type
7.1. Introduction
7.2. Chemotherapy Pump
7.3. Insulin Pump
7.3.1. Patch Pump
7.3.2. Tethered Pump
7.4. Neurostimulator Pump
7.4.1. Deep Brain Stimulator
7.4.2. Spinal Cord Stimulator
7.5. Pain Management Pump
7.5.1. Continuous Rate Pump
7.5.1.1. Multi Rate Pump
7.5.1.2. Single Rate Pump
7.5.2. Patient Controlled Pump
7.5.2.1. Basal Rate Pump
7.5.2.2. Demand Dose Pump
7.6. Infusion Pump
8. Smart Implantable Pumps Market, by Implant Location
8.1. Introduction
8.2. Intracerebral
8.3. Intrathecal
8.4. Subcutaneous
9. Smart Implantable Pumps Market, by Technology
9.1. Introduction
9.2. Programmable Pumps
9.3. Non-Programmable Pumps
9.4. Smart Implantable Pumps
9.4.1. Sensor-Integrated Pumps
9.4.2. AI-assisted Dosing Pumps
9.5. Wireless-Controlled Pumps
9.6. IoT-enabled Connected Pumps
10. Smart Implantable Pumps Market, by Patient Type
10.1. Introduction
10.2. Adult
10.3. Pediatric
10.4. Geriatric
11. Smart Implantable Pumps Market, by Application
11.1. Introduction
11.2. Diabetes Management
11.3. Neurological Disorder Management
11.4. Oncology Therapy
11.5. Pain Management
11.5.1. Chronic Pain Therapy
11.5.2. Cancer Pain Management
12. Smart Implantable Pumps Market, by End User
12.1. Introduction
12.2. Hospitals
12.3. Ambulatory Surgical Centers
12.4. Home Healthcare Settings
12.5. Rehabilitation Centers
13. Smart Implantable Pumps Market, by Distribution Channel
13.1. Introduction
13.2. Offline
13.3. Online
14. Smart Implantable Pumps Market, by Region
14.1. Asia-Pacific
14.2. North America
14.3. Latin America
14.4. Europe
14.5. Middle East
14.6. Africa
15. Smart Implantable Pumps Market, by Group
15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO
16. Smart Implantable Pumps Market, by Country
16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea
17. Competitive Landscape
17.1. Market Share Analysis, 2025
17.2. FPNV Positioning Matrix, 2025
17.3. Market Concentration Analysis, 2025
17.3.1. Concentration Ratio (CR)
17.3.2. Herfindahl Hirschman Index (HHI)
17.4. Recent Developments & Impact Analysis, 2025
17.5. Product Portfolio Analysis, 2025
17.6. Benchmarking Analysis, 2025
18. Company Profiles
18.1. Abbott Laboratories
18.2. Avanos Medical Inc
18.3. B. Braun Melsungen AG
18.4. Baxter International Inc
18.5. Becton Dickinson and Company
18.6. Berlin Heart GmbH
18.7. Boston Scientific Corporation
18.8. Cognos Therapeutics Inc
18.9. Debiotech S.A.
18.10. Flowonix Medical Inc
18.11. Fresenius SE & Co. KGaA
18.12. ICU Medical Inc
18.13. Insulet Corporation
18.14. Intera Oncology Inc
18.15. Johnson & Johnson Services, Inc.
18.16. Medtronic plc
18.17. MicroPort Scientific Corporation
18.18. MPS Microsystems
18.19. Shenzhen Mindray Bio-Medical Electronics Co Ltd
18.20. Smiths Group plc
18.21. Tandem Diabetes Care Inc
18.22. Terumo Corporation
18.23. Tricumed Medizintechnik GmbH
18.24. United Therapeutics Corporation
18.25. W. L. Gore & Associates Inc
List of Figures
FIGURE 1. GLOBAL SMART IMPLANTABLE PUMPS MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL SMART IMPLANTABLE PUMPS MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL SMART IMPLANTABLE PUMPS MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL SMART IMPLANTABLE PUMPS MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL SMART IMPLANTABLE PUMPS MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL SMART IMPLANTABLE PUMPS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL SMART IMPLANTABLE PUMPS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL SMART IMPLANTABLE PUMPS MARKET SIZE, BY IMPLANT LOCATION, 2025 VS 2032 (%)
FIGURE 9. GLOBAL SMART IMPLANTABLE PUMPS MARKET SIZE, BY IMPLANT LOCATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL SMART IMPLANTABLE PUMPS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
FIGURE 11. GLOBAL SMART IMPLANTABLE PUMPS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL SMART IMPLANTABLE PUMPS MARKET SIZE, BY PATIENT TYPE, 2025 VS 2032 (%)
FIGURE 13. GLOBAL SMART IMPLANTABLE PUMPS MARKET SIZE, BY PATIENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL SMART IMPLANTABLE PUMPS MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 15. GLOBAL SMART IMPLANTABLE PUMPS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL SMART IMPLANTABLE PUMPS MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 17. GLOBAL SMART IMPLANTABLE PUMPS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL SMART IMPLANTABLE PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
FIGURE 19. GLOBAL SMART IMPLANTABLE PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL SMART IMPLANTABLE PUMPS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 21. GLOBAL SMART IMPLANTABLE PUMPS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL SMART IMPLANTABLE PUMPS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 23. GLOBAL SMART IMPLANTABLE PUMPS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL SMART IMPLANTABLE PUMPS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 25. GLOBAL SMART IMPLANTABLE PUMPS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 26. GLOBAL SMART IMPLANTABLE PUMPS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 27. GLOBAL SMART IMPLANTABLE PUMPS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL SMART IMPLANTABLE PUMPS MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL SMART IMPLANTABLE PUMPS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL SMART IMPLANTABLE PUMPS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL CHEMOTHERAPY PUMP MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL CHEMOTHERAPY PUMP MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL CHEMOTHERAPY PUMP MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL INSULIN PUMP MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL INSULIN PUMP MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL INSULIN PUMP MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL PATCH PUMP MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL PATCH PUMP MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL PATCH PUMP MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL TETHERED PUMP MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL TETHERED PUMP MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL TETHERED PUMP MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL NEUROSTIMULATOR PUMP MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL NEUROSTIMULATOR PUMP MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL NEUROSTIMULATOR PUMP MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL DEEP BRAIN STIMULATOR MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL DEEP BRAIN STIMULATOR MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL DEEP BRAIN STIMULATOR MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL SPINAL CORD STIMULATOR MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL SPINAL CORD STIMULATOR MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL SPINAL CORD STIMULATOR MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL PAIN MANAGEMENT PUMP MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL PAIN MANAGEMENT PUMP MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL PAIN MANAGEMENT PUMP MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL CONTINUOUS RATE PUMP MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL CONTINUOUS RATE PUMP MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL CONTINUOUS RATE PUMP MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL MULTI RATE PUMP MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL MULTI RATE PUMP MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL MULTI RATE PUMP MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL SINGLE RATE PUMP MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL SINGLE RATE PUMP MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL SINGLE RATE PUMP MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL PATIENT CONTROLLED PUMP MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL PATIENT CONTROLLED PUMP MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL PATIENT CONTROLLED PUMP MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL BASAL RATE PUMP MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL BASAL RATE PUMP MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL BASAL RATE PUMP MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL DEMAND DOSE PUMP MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL DEMAND DOSE PUMP MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL DEMAND DOSE PUMP MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL INFUSION PUMP MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL INFUSION PUMP MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL INFUSION PUMP MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL SMART IMPLANTABLE PUMPS MARKET SIZE, BY IMPLANT LOCATION, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL INTRACEREBRAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL INTRACEREBRAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL INTRACEREBRAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL INTRATHECAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL INTRATHECAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL INTRATHECAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL SUBCUTANEOUS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL SUBCUTANEOUS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL SUBCUTANEOUS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL SMART IMPLANTABLE PUMPS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL PROGRAMMABLE PUMPS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL PROGRAMMABLE PUMPS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL PROGRAMMABLE PUMPS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL NON-PROGRAMMABLE PUMPS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL NON-PROGRAMMABLE PUMPS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL NON-PROGRAMMABLE PUMPS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL SMART IMPLANTABLE PUMPS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL SMART IMPLANTABLE PUMPS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL SMART IMPLANTABLE PUMPS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL SENSOR-INTEGRATED PUMPS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL SENSOR-INTEGRATED PUMPS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL SENSOR-INTEGRATED PUMPS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL AI-ASSISTED DOSING PUMPS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL AI-ASSISTED DOSING PUMPS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL AI-ASSISTED DOSING PUMPS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL WIRELESS-CONTROLLED PUMPS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL WIRELESS-CONTROLLED PUMPS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL WIRELESS-CONTROLLED PUMPS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL IOT-ENABLED CONNECTED PUMPS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL IOT-ENABLED CONNECTED PUMPS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL IOT-ENABLED CONNECTED PUMPS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL SMART IMPLANTABLE PUMPS MARKET SIZE, BY PATIENT TYPE, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL ADULT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL ADULT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL GERIATRIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL GERIATRIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL GERIATRIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL SMART IMPLANTABLE PUMPS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL DIABETES MANAGEMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL DIABETES MANAGEMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL DIABETES MANAGEMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL NEUROLOGICAL DISORDER MANAGEMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL NEUROLOGICAL DISORDER MANAGEMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL NEUROLOGICAL DISORDER MANAGEMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL ONCOLOGY THERAPY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL ONCOLOGY THERAPY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL ONCOLOGY THERAPY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL PAIN MANAGEMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL PAIN MANAGEMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL CHRONIC PAIN THERAPY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL CHRONIC PAIN THERAPY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL CHRONIC PAIN THERAPY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 107. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 108. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 109. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 110. GLOBAL SMART IMPLANTABLE PUMPS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 111. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 112. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 113. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 114. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 115. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 116. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 117. GLOBAL HOME HEALTHCARE SETTINGS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 118. GLOBAL HOME HEALTHCARE SETTINGS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 119. GLOBAL HOME HEALTHCARE SETTINGS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 120. GLOBAL REHABILITATION CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 121. GLOBAL REHABILITATION CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 122. GLOBAL REHABILITATION CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 123. GLOBAL SMART IMPLANTABLE PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 124. GLOBAL OFFLINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 125. GLOBAL OFFLINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 126. GLOBAL OFFLINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 127. GLOBAL ONLINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 128. GLOBAL ONLINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 129. GLOBAL ONLINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 130. GLOBAL SMART IMPLANTABLE PUMPS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 131. ASIA-PACIFIC SMART IMPLANTABLE PUMPS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 132. ASIA-PACIFIC SMART IMPLANTABLE PUMPS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 133. ASIA-PACIFIC SMART IMPLANTABLE PUMPS MARKET SIZE, BY INSULIN PUMP, 2017-2032 (USD MILLION)
TABLE 134. ASIA-PACIFIC SMART IMPLANTABLE PUMPS MARKET SIZE, BY NEUROSTIMULATOR PUMP, 2017-2032 (USD MILLION)
TABLE 135. ASIA-PACIFIC SMART IMPLANTABLE PUMPS MARKET SIZE, BY PAIN MANAGEMENT PUMP, 2017-2032 (USD MILLION)
TABLE 136. ASIA-PACIFIC SMART IMPLANTABLE PUMPS MARKET SIZE, BY CONTINUOUS RATE PUMP, 2017-2032 (USD MILLION)
TABLE 137. ASIA-PACIFIC SMART IMPLANTABLE PUMPS MARKET SIZE, BY PATIENT CONTROLLED PUMP, 2017-2032 (USD MILLION)
TABLE 138. ASIA-PACIFIC SMART IMPLANTABLE PUMPS MARKET SIZE, BY IMPLANT LOCATION, 2017-2032 (USD MILLION)
TABLE 139. ASIA-PACIFIC SMART IMPLANTABLE PUMPS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 140. ASIA-PACIFIC SMART IMPLANTABLE PUMPS MARKET SIZE, BY SMART IMPLANTABLE PUMPS, 2017-2032 (USD MILLION)
TABLE 141. ASIA-PACIFIC SMART IMPLANTABLE PUMPS MARKET SIZE, BY PATIENT TYPE, 2017-2032 (USD MILLION)
TABLE 142. ASIA-PACIFIC SMART IMPLANTABLE PUMPS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 143. ASIA-PACIFIC SMART IMPLANTABLE PUMPS MARKET SIZE, BY PAIN MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 144. ASIA-PACIFIC SMART IMPLANTABLE PUMPS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 145. ASIA-PACIFIC SMART IMPLANTABLE PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 146. NORTH AMERICA SMART IMPLANTABLE PUMPS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 147. NORTH AMERICA SMART IMPLANTABLE PUMPS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 148. NORTH AMERICA SMART IMPLANTABLE PUMPS MARKET SIZE, BY INSULIN PUMP, 2017-2032 (USD MILLION)
TABLE 149. NORTH AMERICA SMART IMPLANTABLE PUMPS MARKET SIZE, BY NEUROSTIMULATOR PUMP, 2017-2032 (USD MILLION)
TABLE 150. NORTH AMERICA SMART IMPLANTABLE PUMPS MARKET SIZE, BY PAIN MANAGEMENT PUMP, 2017-2032 (USD MILLION)
TABLE 151. NORTH AMERICA SMART IMPLANTABLE PUMPS MARKET SIZE, BY CONTINUOUS RATE PUMP, 2017-2032 (USD MILLION)
TABLE 152. NORTH AMERICA SMART IMPLANTABLE PUMPS MARKET SIZE, BY PATIENT CONTROLLED PUMP, 2017-2032 (USD MILLION)
TABLE 153. NORTH AMERICA SMART IMPLANTABLE PUMPS MARKET SIZE, BY IMPLANT LOCATION, 2017-2032 (USD MILLION)
TABLE 154. NORTH AMERICA SMART IMPLANTABLE PUMPS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 155. NORTH AMERICA SMART IMPLANTABLE PUMPS MARKET SIZE, BY SMART IMPLANTABLE PUMPS, 2017-2032 (USD MILLION)
TABLE 156. NORTH AMERICA SMART IMPLANTABLE PUMPS MARKET SIZE, BY PATIENT TYPE, 2017-2032 (USD MILLION)
TABLE 157. NORTH AMERICA SMART IMPLANTABLE PUMPS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 158. NORTH AMERICA SMART IMPLANTABLE PUMPS MARKET SIZE, BY PAIN MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 159. NORTH AMERICA SMART IMPLANTABLE PUMPS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 160. NORTH AMERICA SMART IMPLANTABLE PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 161. LATIN AMERICA SMART IMPLANTABLE PUMPS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 162. LATIN AMERICA SMART IMPLANTABLE PUMPS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 163. LATIN AMERICA SMART IMPLANTABLE PUMPS MARKET SIZE, BY INSULIN PUMP, 2017-2032 (USD MILLION)
TABLE 164. LATIN AMERICA SMART IMPLANTABLE PUMPS MARKET SIZE, BY NEUROSTIMULATOR PUMP, 2017-2032 (USD MILLION)
TABLE 165. LATIN AMERICA SMART IMPLANTABLE PUMPS MARKET SIZE, BY PAIN MANAGEMENT PUMP, 2017-2032 (USD MILLION)
TABLE 166. LATIN AMERICA SMART IMPLANTABLE PUMPS MARKET SIZE, BY CONTINUOUS RATE PUMP, 2017-2032 (USD MILLION)
TABLE 167. LATIN AMERICA SMART IMPLANTABLE PUMPS MARKET SIZE, BY PATIENT CONTROLLED PUMP, 2017-2032 (USD MILLION)
TABLE 168. LATIN AMERICA SMART IMPLANTABLE PUMPS MARKET SIZE, BY IMPLANT LOCATION, 2017-2032 (USD MILLION)
TABLE 169. LATIN AMERICA SMART IMPLANTABLE PUMPS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 170. LATIN AMERICA SMART IMPLANTABLE PUMPS MARKET SIZE, BY SMART IMPLANTABLE PUMPS, 2017-2032 (USD MILLION)
TABLE 171. LATIN AMERICA SMART IMPLANTABLE PUMPS MARKET SIZE, BY PATIENT TYPE, 2017-2032 (USD MILLION)
TABLE 172. LATIN AMERICA SMART IMPLANTABLE PUMPS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 173. LATIN AMERICA SMART IMPLANTABLE PUMPS MARKET SIZE, BY PAIN MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 174. LATIN AMERICA SMART IMPLANTABLE PUMPS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 175. LATIN AMERICA SMART IMPLANTABLE PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 176. EUROPE SMART IMPLANTABLE PUMPS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 177. EUROPE SMART IMPLANTABLE PUMPS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 178. EUROPE SMART IMPLANTABLE PUMPS MARKET SIZE, BY INSULIN PUMP, 2017-2032 (USD MILLION)
TABLE 179. EUROPE SMART IMPLANTABLE PUMPS MARKET SIZE, BY NEUROSTIMULATOR PUMP, 2017-2032 (USD MILLION)
TABLE 180. EUROPE SMART IMPLANTABLE PUMPS MARKET SIZE, BY PAIN MANAGEMENT PUMP, 2017-2032 (USD MILLION)
TABLE 181. EUROPE SMART IMPLANTABLE PUMPS MARKET SIZE, BY CONTINUOUS RATE PUMP, 2017-2032 (USD MILLION)
TABLE 182. EUROPE SMART IMPLANTABLE PUMPS MARKET SIZE, BY PATIENT CONTROLLED PUMP, 2017-2032 (USD MILLION)
TABLE 183. EUROPE SMART IMPLANTABLE PUMPS MARKET SIZE, BY IMPLANT LOCATION, 2017-2032 (USD MILLION)
TABLE 184. EUROPE SMART IMPLANTABLE PUMPS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 185. EUROPE SMART IMPLANTABLE PUMPS MARKET SIZE, BY SMART IMPLANTABLE PUMPS, 2017-2032 (USD MILLION)
TABLE 186. EUROPE SMART IMPLANTABLE PUMPS MARKET SIZE, BY PATIENT TYPE, 2017-2032 (USD MILLION)
TABLE 187. EUROPE SMART IMPLANTABLE PUMPS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 188. EUROPE SMART IMPLANTABLE PUMPS MARKET SIZE, BY PAIN MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 189. EUROPE SMART IMPLANTABLE PUMPS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 190. EUROPE SMART IMPLANTABLE PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 191. MIDDLE EAST SMART IMPLANTABLE PUMPS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 192. MIDDLE EAST SMART IMPLANTABLE PUMPS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 193. MIDDLE EAST SMART IMPLANTABLE PUMPS MARKET SIZE, BY INSULIN PUMP, 2017-2032 (USD MILLION)
TABLE 194. MIDDLE EAST SMART IMPLANTABLE PUMPS MARKET SIZE, BY NEUROSTIMULATOR PUMP, 2017-2032 (USD MILLION)
TABLE 195. MIDDLE EAST SMART IMPLANTABLE PUMPS MARKET SIZE, BY PAIN MANAGEMENT PUMP, 2017-2032 (USD MILLION)
TABLE 196. MIDDLE EAST SMART IMPLANTABLE PUMPS MARKET SIZE, BY CONTINUOUS RATE PUMP, 2017-2032 (USD MILLION)
TABLE 197. MIDDLE EAST SMART IMPLANTABLE PUMPS MARKET SIZE, BY PATIENT CONTROLLED PUMP, 2017-2032 (USD MILLION)
TABLE 198. MIDDLE EAST SMART IMPLANTABLE PUMPS MARKET SIZE, BY IMPLANT LOCATION, 2017-2032 (USD MILLION)
TABLE 199. MIDDLE EAST SMART IMPLANTABLE PUMPS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 200. MIDDLE EAST SMART IMPLANTABLE PUMPS MARKET SIZE, BY SMART IMPLANTABLE PUMPS, 2017-2032 (USD MILLION)
TABLE 201. MIDDLE EAST SMART IMPLANTABLE PUMPS MARKET SIZE, BY PATIENT TYPE, 2017-2032 (USD MILLION)
TABLE 202. MIDDLE EAST SMART IMPLANTABLE PUMPS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 203. MIDDLE EAST SMART IMPLANTABLE PUMPS MARKET SIZE, BY PAIN MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 204. MIDDLE EAST SMART IMPLANTABLE PUMPS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 205. MIDDLE EAST SMART IMPLANTABLE PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 206. AFRICA SMART IMPLANTABLE PUMPS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 207. AFRICA SMART IMPLANTABLE PUMPS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 208. AFRICA SMART IMPLANTABLE PUMPS MARKET SIZE, BY INSULIN PUMP, 2017-2032 (USD MILLION)
TABLE 209. AFRICA SMART IMPLANTABLE PUMPS MARKET SIZE, BY NEUROSTIMULATOR PUMP, 2017-2032 (USD MILLION)
TABLE 210. AFRICA SMART IMPLANTABLE PUMPS MARKET SIZE, BY PAIN MANAGEMENT PUMP, 2017-2032 (USD MILLION)
TABLE 211. AFRICA SMART IMPLANTABLE PUMPS MARKET SIZE, BY CONTINUOUS RATE PUMP, 2017-2032 (USD MILLION)
TABLE 212. AFRICA SMART IMPLANTABLE PUMPS MARKET SIZE, BY PATIENT CONTROLLED PUMP, 2017-2032 (USD MILLION)
TABLE 213. AFRICA SMART IMPLANTABLE PUMPS MARKET SIZE, BY IMPLANT LOCATION, 2017-2032 (USD MILLION)
TABLE 214. AFRICA SMART IMPLANTABLE PUMPS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 215. AFRICA SMART IMPLANTABLE PUMPS MARKET SIZE, BY SMART IMPLANTABLE PUMPS, 2017-2032 (USD MILLION)
TABLE 216. AFRICA SMART IMPLANTABLE PUMPS MARKET SIZE, BY PATIENT TYPE, 2017-2032 (USD MILLION)
TABLE 217. AFRICA SMART IMPLANTABLE PUMPS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 218. AFRICA SMART IMPLANTABLE PUMPS MARKET SIZE, BY PAIN MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 219. AFRICA SMART IMPLANTABLE PUMPS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 220. AFRICA SMART IMPLANTABLE PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 221. GLOBAL SMART IMPLANTABLE PUMPS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 222. ASEAN SMART IMPLANTABLE PUMPS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 223. ASEAN SMART IMPLANTABLE PUMPS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 224. ASEAN SMART IMPLANTABLE PUMPS MARKET SIZE, BY INSULIN PUMP, 2017-2032 (USD MILLION)
TABLE 225. ASEAN SMART IMPLANTABLE PUMPS MARKET SIZE, BY NEUROSTIMULATOR PUMP, 2017-2032 (USD MILLION)
TABLE 226. ASEAN SMART IMPLANTABLE PUMPS MARKET SIZE, BY PAIN MANAGEMENT PUMP, 2017-2032 (USD MILLION)
TABLE 227. ASEAN SMART IMPLANTABLE PUMPS MARKET SIZE, BY CONTINUOUS RATE PUMP, 2017-2032 (USD MILLION)
TABLE 228. ASEAN SMART IMPLANTABLE PUMPS MARKET SIZE, BY PATIENT CONTROLLED PUMP, 2017-2032 (USD MILLION)
TABLE 229. ASEAN SMART IMPLANTABLE PUMPS MARKET SIZE, BY IMPLANT LOCATION, 2017-2032 (USD MILLION)
TABLE 230. ASEAN SMART IMPLANTABLE PUMPS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 231. ASEAN SMART IMPLANTABLE PUMPS MARKET SIZE, BY SMART IMPLANTABLE PUMPS, 2017-2032 (USD MILLION)
TABLE 232. ASEAN SMART IMPLANTABLE PUMPS MARKET SIZE, BY PATIENT TYPE, 2017-2032 (USD MILLION)
TABLE 233. ASEAN SMART IMPLANTABLE PUMPS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 234. ASEAN SMART IMPLANTABLE PUMPS MARKET SIZE, BY PAIN MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 235. ASEAN SMART IMPLANTABLE PUMPS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 236. ASEAN SMART IMPLANTABLE PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 237. GCC SMART IMPLANTABLE PUMPS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 238. GCC SMART IMPLANTABLE PUMPS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 239. GCC SMART IMPLANTABLE PUMPS MARKET SIZE, BY INSULIN PUMP, 2017-2032 (USD MILLION)
TABLE 240. GCC SMART IMPLANTABLE PUMPS MARKET SIZE, BY NEUROSTIMULATOR PUMP, 2017-2032 (USD MILLION)
TABLE 241. GCC SMART IMPLANTABLE PUMPS MARKET SIZE, BY PAIN MANAGEMENT PUMP, 2017-2032 (USD MILLION)
TABLE 242. GCC SMART IMPLANTABLE PUMPS MARKET SIZE, BY CONTINUOUS RATE PUMP, 2017-2032 (USD MILLION)
TABLE 243. GCC SMART IMPLANTABLE PUMPS MARKET SIZE, BY PATIENT CONTROLLED PUMP, 2017-2032 (USD MILLION)
TABLE 244. GCC SMART IMPLANTABLE PUMPS MARKET SIZE, BY IMPLANT LOCATION, 2017-2032 (USD MILLION)
TABLE 245. GCC SMART IMPLANTABLE PUMPS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 246. GCC SMART IMPLANTABLE PUMPS MARKET SIZE, BY SMART IMPLANTABLE PUMPS, 2017-2032 (USD MILLION)
TABLE 247. GCC SMART IMPLANTABLE PUMPS MARKET SIZE, BY PATIENT TYPE, 2017-2032 (USD MILLION)
TABLE 248. GCC SMART IMPLANTABLE PUMPS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 249. GCC SMART IMPLANTABLE PUMPS MARKET SIZE, BY PAIN MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 250. GCC SMART IMPLANTABLE PUMPS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 251. GCC SMART IMPLANTABLE PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 252. EUROPEAN UNION SMART IMPLANTABLE PUMPS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 253. EUROPEAN UNION SMART IMPLANTABLE PUMPS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 254. EUROPEAN UNION SMART IMPLANTABLE PUMPS MARKET SIZE, BY INSULIN PUMP, 2017-2032 (USD MILLION)
TABLE 255. EUROPEAN UNION SMART IMPLANTABLE PUMPS MARKET SIZE, BY NEUROSTIMULATOR PUMP, 2017-2032 (USD MILLION)
TABLE 256. EUROPEAN UNION SMART IMPLANTABLE PUMPS MARKET SIZE, BY PAIN MANAGEMENT PUMP, 2017-2032 (USD MILLION)
TABLE 257. EUROPEAN UNION SMART IMPLANTABLE PUMPS MARKET SIZE, BY CONTINUOUS RATE PUMP, 2017-2032 (USD MILLION)
TABLE 258. EUROPEAN UNION SMART IMPLANTABLE PUMPS MARKET SIZE, BY PATIENT CONTROLLED PUMP, 2017-2032 (USD MILLION)
TABLE 259. EUROPEAN UNION SMART IMPLANTABLE PUMPS MARKET SIZE, BY IMPLANT LOCATION, 2017-2032 (USD MILLION)
TABLE 260. EUROPEAN UNION SMART IMPLANTABLE PUMPS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 261. EUROPEAN UNION SMART IMPLANTABLE PUMPS MARKET SIZE, BY SMART IMPLANTABLE PUMPS, 2017-2032 (USD MILLION)
TABLE 262. EUROPEAN UNION SMART IMPLANTABLE PUMPS MARKET SIZE, BY PATIENT TYPE, 2017-2032 (USD MILLION)
TABLE 263. EUROPEAN UNION SMART IMPLANTABLE PUMPS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 264. EUROPEAN UNION SMART IMPLANTABLE PUMPS MARKET SIZE, BY PAIN MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 265. EUROPEAN UNION SMART IMPLANTABLE PUMPS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 266. EUROPEAN UNION SMART IMPLANTABLE PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 267. BRICS SMART IMPLANTABLE PUMPS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 268. BRICS SMART IMPLANTABLE PUMPS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 269. BRICS SMART IMPLANTABLE PUMPS MARKET SIZE, BY INSULIN PUMP, 2017-2032 (USD MILLION)
TABLE 270. BRICS SMART IMPLANTABLE PUMPS MARKET SIZE, BY NEUROSTIMULATOR PUMP, 2017-2032 (USD MILLION)
TABLE 271. BRICS SMART IMPLANTABLE PUMPS MARKET SIZE, BY PAIN MANAGEMENT PUMP, 2017-2032 (USD MILLION)
TABLE 272. BRICS SMART IMPLANTABLE PUMPS MARKET SIZE, BY CONTINUOUS RATE PUMP, 2017-2032 (USD MILLION)
TABLE 273. BRICS SMART IMPLANTABLE PUMPS MARKET SIZE, BY PATIENT CONTROLLED PUMP, 2017-2032 (USD MILLION)
TABLE 274. BRICS SMART IMPLANTABLE PUMPS MARKET SIZE, BY IMPLANT LOCATION, 2017-2032 (USD MILLION)
TABLE 275. BRICS SMART IMPLANTABLE PUMPS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 276. BRICS SMART IMPLANTABLE PUMPS MARKET SIZE, BY SMART IMPLANTABLE PUMPS, 2017-2032 (USD MILLION)
TABLE 277. BRICS SMART IMPLANTABLE PUMPS MARKET SIZE, BY PATIENT TYPE, 2017-2032 (USD MILLION)
TABLE 278. BRICS SMART IMPLANTABLE PUMPS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 279. BRICS SMART IMPLANTABLE PUMPS MARKET SIZE, BY PAIN MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 280. BRICS SMART IMPLANTABLE PUMPS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 281. BRICS SMART IMPLANTABLE PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 282. G7 SMART IMPLANTABLE PUMPS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 283. G7 SMART IMPLANTABLE PUMPS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 284. G7 SMART IMPLANTABLE PUMPS MARKET SIZE, BY INSULIN PUMP, 2017-2032 (USD MILLION)
TABLE 285. G7 SMART IMPLANTABLE PUMPS MARKET SIZE, BY NEUROSTIMULATOR PUMP, 2017-2032 (USD MILLION)
TABLE 286. G7 SMART IMPLANTABLE PUMPS MARKET SIZE, BY PAIN MANAGEMENT PUMP, 2017-2032 (USD MILLION)
TABLE 287. G7 SMART IMPLANTABLE PUMPS MARKET SIZE, BY CONTINUOUS RATE PUMP, 2017-2032 (USD MILLION)
TABLE 288. G7 SMART IMPLANTABLE PUMPS MARKET SIZE, BY PATIENT CONTROLLED PUMP, 2017-2032 (USD MILLION)
TABLE 289. G7 SMART IMPLANTABLE PUMPS MARKET SIZE, BY IMPLANT LOCATION, 2017-2032 (USD MILLION)
TABLE 290. G7 SMART IMPLANTABLE PUMPS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 291. G7 SMART IMPLANTABLE PUMPS MARKET SIZE, BY SMART IMPLANTABLE PUMPS, 2017-2032 (USD MILLION)
TABLE 292. G7 SMART IMPLANTABLE PUMPS MARKET SIZE, BY PATIENT TYPE, 2017-2032 (USD MILLION)
TABLE 293. G7 SMART IMPLANTABLE PUMPS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 294. G7 SMART IMPLANTABLE PUMPS MARKET SIZE, BY PAIN MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 295. G7 SMART IMPLANTABLE PUMPS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 296. G7 SMART IMPLANTABLE PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 297. NATO SMART IMPLANTABLE PUMPS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 298. NATO SMART IMPLANTABLE PUMPS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 299. NATO SMART IMPLANTABLE PUMPS MARKET SIZE, BY INSULIN PUMP, 2017-2032 (USD MILLION)
TABLE 300. NATO SMART IMPLANTABLE PUMPS MARKET SIZE, BY NEUROSTIMULATOR PUMP, 2017-2032 (USD MILLION)
TABLE 301. NATO SMART IMPLANTABLE PUMPS MARKET SIZE, BY PAIN MANAGEMENT PUMP, 2017-2032 (USD MILLION)
TABLE 302. NATO SMART IMPLANTABLE PUMPS MARKET SIZE, BY CONTINUOUS RATE PUMP, 2017-2032 (USD MILLION)
TABLE 303. NATO SMART IMPLANTABLE PUMPS MARKET SIZE, BY PATIENT CONTROLLED PUMP, 2017-2032 (USD MILLION)
TABLE 304. NATO SMART IMPLANTABLE PUMPS MARKET SIZE, BY IMPLANT LOCATION, 2017-2032 (USD MILLION)
TABLE 305. NATO SMART IMPLANTABLE PUMPS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 306. NATO SMART IMPLANTABLE PUMPS MARKET SIZE, BY SMART IMPLANTABLE PUMPS, 2017-2032 (USD MILLION)
TABLE 307. NATO SMART IMPLANTABLE PUMPS MARKET SIZE, BY PATIENT TYPE, 2017-2032 (USD MILLION)
TABLE 308. NATO SMART IMPLANTABLE PUMPS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 309. NATO SMART IMPLANTABLE PUMPS MARKET SIZE, BY PAIN MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 310. NATO SMART IMPLANTABLE PUMPS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 311. NATO SMART IMPLANTABLE PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 312. GLOBAL SMART IMPLANTABLE PUMPS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 313. UNITED STATES SMART IMPLANTABLE PUMPS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 314. UNITED STATES SMART IMPLANTABLE PUMPS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 315. UNITED STATES SMART IMPLANTABLE PUMPS MARKET SIZE, BY INSULIN PUMP, 2017-2032 (USD MILLION)
TABLE 316. UNITED STATES SMART IMPLANTABLE PUMPS MARKET SIZE, BY NEUROSTIMULATOR PUMP, 2017-2032 (USD MILLION)
TABLE 317. UNITED STATES SMART IMPLANTABLE PUMPS MARKET SIZE, BY PAIN MANAGEMENT PUMP, 2017-2032 (USD MILLION)
TABLE 318. UNITED STATES SMART IMPLANTABLE PUMPS MARKET SIZE, BY CONTINUOUS RATE PUMP, 2017-2032 (USD MILLION)
TABLE 319. UNITED STATES SMART IMPLANTABLE PUMPS MARKET SIZE, BY PATIENT CONTROLLED PUMP, 2017-2032 (USD MILLION)
TABLE 320. UNITED STATES SMART IMPLANTABLE PUMPS MARKET SIZE, BY IMPLANT LOCATION, 2017-2032 (USD MILLION)
TABLE 321. UNITED STATES SMART IMPLANTABLE PUMPS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 322. UNITED STATES SMART IMPLANTABLE PUMPS MARKET SIZE, BY SMART IMPLANTABLE PUMPS, 2017-2032 (USD MILLION)
TABLE 323. UNITED STATES SMART IMPLANTABLE PUMPS MARKET SIZE, BY PATIENT TYPE, 2017-2032 (USD MILLION)
TABLE 324. UNITED STATES SMART IMPLANTABLE PUMPS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 325. UNITED STATES SMART IMPLANTABLE PUMPS MARKET SIZE, BY PAIN MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 326. UNITED STATES SMART IMPLANTABLE PUMPS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 327. UNITED STATES SMART IMPLANTABLE PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 328. CANADA SMART IMPLANTABLE PUMPS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 329. CANADA SMART IMPLANTABLE PUMPS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 330. CANADA SMART IMPLANTABLE PUMPS MARKET SIZE, BY INSULIN PUMP, 2017-2032 (USD MILLION)
TABLE 331. CANADA SMART IMPLANTABLE PUMPS MARKET SIZE, BY NEUROSTIMULATOR PUMP, 2017-2032 (USD MILLION)
TABLE 332. CANADA SMART IMPLANTABLE PUMPS MARKET SIZE, BY PAIN MANAGEMENT PUMP, 2017-2032 (USD MILLION)
TABLE 333. CANADA SMART IMPLANTABLE PUMPS MARKET SIZE, BY CONTINUOUS RATE PUMP, 2017-2032 (USD MILLION)
TABLE 334. CANADA SMART IMPLANTABLE PUMPS MARKET SIZE, BY PATIENT CONTROLLED PUMP, 2017-2032 (USD MILLION)
TABLE 335. CANADA SMART IMPLANTABLE PUMPS MARKET SIZE, BY IMPLANT LOCATION, 2017-2032 (USD MILLION)
TABLE 336. CANADA SMART IMPLANTABLE PUMPS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 337. CANADA SMART IMPLANTABLE PUMPS MARKET SIZE, BY SMART IMPLANTABLE PUMPS, 2017-2032 (USD MILLION)
TABLE 338. CANADA SMART IMPLANTABLE PUMPS MARKET SIZE, BY PATIENT TYPE, 2017-2032 (USD MILLION)
TABLE 339. CANADA SMART IMPLANTABLE PUMPS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 340. CANADA SMART IMPLANTABLE PUMPS MARKET SIZE, BY PAIN MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 341. CANADA SMART IMPLANTABLE PUMPS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 342. CANADA SMART IMPLANTABLE PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 343. MEXICO SMART IMPLANTABLE PUMPS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 344. MEXICO SMART IMPLANTABLE PUMPS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 345. MEXICO SMART IMPLANTABLE PUMPS MARKET SIZE, BY INSULIN PUMP, 2017-2032 (USD MILLION)
TABLE 346. MEXICO SMART IMPLANTABLE PUMPS MARKET SIZE, BY NEUROSTIMULATOR PUMP, 2017-2032 (USD MILLION)
TABLE 347. MEXICO SMART IMPLANTABLE PUMPS

Companies Mentioned

  • Abbott Laboratories
  • Avanos Medical Inc
  • B. Braun Melsungen AG
  • Baxter International Inc
  • Becton Dickinson and Company
  • Berlin Heart GmbH
  • Boston Scientific Corporation
  • Cognos Therapeutics Inc
  • Debiotech S.A.
  • Flowonix Medical Inc
  • Fresenius SE & Co. KGaA
  • ICU Medical Inc
  • Insulet Corporation
  • Intera Oncology Inc
  • Johnson & Johnson Services, Inc.
  • Medtronic plc
  • MicroPort Scientific Corporation
  • MPS Microsystems
  • Shenzhen Mindray Bio-Medical Electronics Co Ltd
  • Smiths Group plc
  • Tandem Diabetes Care Inc
  • Terumo Corporation
  • Tricumed Medizintechnik GmbH
  • United Therapeutics Corporation
  • W. L. Gore & Associates Inc

Table Information

Report AttributeDetails
No. of Pages192
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 3.19 Billion
Forecasted Market Value ( USD ) by 2032 $ 5.07 Billion
Compound Annual Growth Rate7.8%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Smart Implantable Pumps - Global Strategic Business Report - Product Image

Smart Implantable Pumps - Global Strategic Business Report

  • Report
  • 173 Pages
  • Global
From
Smart Implantable Pumps Market Outlook 2026-2034: Market Share, and Growth Analysis by Pump Type (Perfusion Pumps, Micro Pumps, Programmable Insulin Pumps, Intrathecal Pumps, Drug-Eluting Pumps), Application, End User - Product Image

Smart Implantable Pumps Market Outlook 2026-2034: Market Share, and Growth Analysis by Pump Type (Perfusion Pumps, Micro Pumps, Programmable Insulin Pumps, Intrathecal Pumps, Drug-Eluting Pumps), Application, End User

  • Report
  • 160 Pages
  • Global
From
Smart Implantable Pumps - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Smart Implantable Pumps - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 130 Pages
  • Global
From
Smart Implantable Pumps Market Insights, Competitive Landscape, and Market Forecast - 2033 - Product Image

Smart Implantable Pumps Market Insights, Competitive Landscape, and Market Forecast - 2033

  • Report
  • 192 Pages
  • Global
From
2025 Global Forecast for Smart Implantable Pumps Market (2026-2031): High Tech Outlook Report - Product Image

2025 Global Forecast for Smart Implantable Pumps Market (2026-2031): High Tech Outlook Report

  • Report
  • 132 Pages
  • Global
From

About the Market

The Smart Implantable Pump market is a subset of the Medical Devices industry. It is composed of devices that are implanted into the body and used to deliver medication or other treatments. These pumps are typically powered by batteries and can be programmed to deliver precise doses of medication over a period of time. Smart Implantable Pumps are designed to be more efficient and accurate than traditional pumps, and can be monitored remotely. They are also designed to be more user-friendly, with features such as voice-activated commands and smartphone integration. The Smart Implantable Pump market is growing rapidly, driven by advances in technology and the increasing demand for more efficient and accurate treatments. This market is expected to continue to grow in the coming years, as more people seek out these devices for their medical needs. Some companies in the Smart Implantable Pump market include Medtronic, Abbott, and Johnson & Johnson. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.